| DC Field | Value | Language |
|---|
| dc.contributor.author | Efimenko, S. V. | - |
| dc.contributor.author | Korokin, M. V. | - |
| dc.contributor.author | Gudyrev, O. S. | - |
| dc.contributor.author | Danilenko, L. M. | - |
| dc.contributor.author | Korokina, L. V. | - |
| dc.date.accessioned | 2024-08-23T08:04:38Z | - |
| dc.date.available | 2024-08-23T08:04:38Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.citation | Assessment of the correction of neuroretinal changes using 2-ethyl-6-methyl-3-hydroxypyridinium N-acetyltaurinate in the modeling of POAG / S.V. Efimenko, M.V. Korokin, O.S. Gudyrev [et al.] // Research Results in Pharmacology. - 2024. - Vol.10, №2.-P. 107-117. - Doi: 10.18413/rrpharmacology.10.477. - Refer.: p. 115-116. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/63420 | - |
| dc.description.abstract | The aim: to research the correction possibility of experimental POAG induced by intracameral (i.c.) administration of hyaluronic acid using 2-ethyl-6-methyl-3-hydroxypyridinium N-acetyltaurinate | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | 2-ethyl-6-methyl-3-hydroxypyridinium N-acetyltaurinate | ru |
| dc.subject | primary open-angle glaucoma | ru |
| dc.subject | retinoprotection | ru |
| dc.subject | neuroprotection | ru |
| dc.title | Assessment of the correction of neuroretinal changes using 2-ethyl-6-methyl-3- hydroxypyridinium N-acetyltaurinate in the modeling of POAG | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 10, № 2
|
